FDA OKs expanded use of Roche's Avastin for colon cancer treatment

01/23/2013 | American City Business Journals · Fox Business

The FDA authorized the use of Roche Holding's Avastin, or bevacizumab, with fluoropyrimidine-irinotecan or fluoropyrimidine-oxaliplatin chemotherapy, for patients with metastatic colorectal cancer whose condition worsened after previous treatment with the drug. Avastin was developed by Roche unit Genentech.

View Full Article in:

American City Business Journals · Fox Business

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA